The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 16, 2020
Filed:
Mar. 12, 2014
Applicant:
Nal Pharmaceuticals, Ltd., Hong Kong, CN;
Inventors:
Je Phil Ryoo, Princeton, NJ (US);
Chun Kwong Chu, Hong Kong, CN;
Assignee:
NAL PHARMACEUTICAL GROUP LIMITED, Hong Kong, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7072 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 31/167 (2006.01); A61K 9/06 (2006.01); A61K 47/14 (2017.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/16 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01); A61K 47/42 (2017.01);
U.S. Cl.
CPC ...
A61K 31/7072 (2013.01); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 31/167 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/16 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/38 (2013.01); A61K 47/42 (2013.01);
Abstract
The present invention provides a novel pharmaceutical composition and method of making the same. The composition comprises an effective amount of an antiviral agent and a local anesthetic. The antiviral drug can be sorivudine. The local anesthetic can be lidocaine or its pharmaceutically acceptable salt. Herpes virus infections in humans can be caused by different human herpes viruses, the most common being herpes simplex virus types 1 and 2 (HSV1 and HSV2) and varicella-zoster virus (VZV).